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Summary 
The contribution of microglia in neurological disorders is emerging as a leading driver rather 
than a consequence of pathology. RNAseT2-deficient leukoencephalopathy is a severe 
childhood white matter disorder affecting patients in their first year of life and mimics a 
cytomegalovirus brain infection. The early onset and resemblance of the symptoms to an 
immune response suggest an inflammatory and embryonic origin of the pathology. In this 
study, we identify deficient microglia as an early marker of pathology. Using the ex utero 
development and the optical transparency of an rnaset2-deficient zebrafish model, we found 
that dysfunctional microglia fail to clear apoptotic neurons during brain development. This was 
associated with increased number of apoptotic cells and behavioural defects lasting into 
adulthood. This zebrafish model recapitulates all aspect of the human disease to be used as a 
robust preclinical model. Using microglia-specific depletion and rescue experiments, we 
identified microglia as potential drivers of the pathology and highlight tissue-specific 
approaches as future therapeutic avenues. 
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Introduction 
 
Developmental apoptosis in the CNS allows the brain to eliminate excess neurons produced 
during development (Meier et al., 2000; Nijhawan et al., 2000; Dekkers et al., 2013). Dying 
neurons are cleared by the main phagocyte in the CNSÑthe microgliaÑand this immune 
response is necessary to allow natural clearing of apoptotic neurons. However, disordered 
immunity in the brain is also a feature of many neurological disorders and plays a crucial role 
in the onset and progression of many neurodegenerative and monogenic white matter diseases.  
 
White matter disorders such as leukodystrophies are characterised by myelin defects and white 
matter degeneration. The early onset of clinical symptoms includes loss of motor function and 
cognitive decline, with patients often dying at a young age (Bielschowsky and Henneberg, 
1928). Patients as young as a few months old can present with neurological deficits, suggesting 
a foetal origin of the disease. At least 200 rare leukodystrophies have been identified to date, 
many of which are caused by the dysfunction of oligodendrocytes and subsequent loss of 
myelin integrity (United Leukodystrophy Foundation, 2019). More recently, the contribution 
of microglia and neuroinflammation to disease pathology has been recognised, prompting 
reclassification of these diseases and a requirement for further understanding of the 
mechanisms underlying disease progression (Kevelam et al., 2016; van der Knaap and Bugiani, 
2017).  
 
Neuroinflammation is a major contributor to the progression of leukodystrophies, with 
increased immune activity detected even before the onset of myelin loss. Evidence of 
microglial activation preceded the reduction of myelin viability in post mortem brains of 
patients suffering from metachromatic leukodystrophy (MLD) and X-linked 
adrenoleukodystrophy (X-ALD) (Bergner et al., 2019). Mouse models of KrabbeÕs disease, 
another fatal leukodystrophy, showed similar microglial activation before myelin loss, with 
elevated innate immune markers even before microglial activation (Potter et al., 2013; Snook 
et al., 2014). The phenotype of one of the more prevalent leukodystrophiesÑAicardi Goutires 
Syndrome (AGS)Ñmimics congenital cytomegalovirus brain infection and is classified as an 
interferonopathy to account for the upregulation of type I IFN!induced signal apparently central 
to pathology (Crow and Manel, 2015). Understanding whether the immune system is a driver 
of the disease rather a consequence may uncover new avenues for therapeutic interventions to 
treat these otherwise incurable diseases.  
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The development of animal models to study leukodystrophies in vivo has been invaluable for 
testing therapies (Priller et al., 2001; Biffi et al., 2004; Launay et al., 2017; Marshall et al., 
2018), however many of those models fail to recapitulate the key aspects of the human disease. 
We have previously generated a zebrafish model for the RibonucleaseT2 (RNAseT2)-deficient 
leukoencephalopathy (Haud et al., 2010). Similar to AGS, RNAseT2-deficient 
leukoencephalopathy is another severe leukodystrophy with clinical manifestations resembling 
a congenital cytomegalovirus brain infection. This disorder affects children in their first year 
of life and is characterised by white matter lesions, subcortical cysts and calcification, with 
severe psychomotor and sensorineural hearing impairments (Henneke et al., 2009).  
We and others have shown that loss of RNAseT2 causes a lysosomal storage disorder resulting 
in the accumulation of ribosomal RNA in neurons due to defects in ribosome autophagy 
(ribophagy) (Haud et al., 2010; Hillwig et al., 2011). Adult rnaset2-deficient zebrafish develop 
white matter lesions in adult brains, recapitulating this aspect of the human pathology. 
Furthermore rnaset2 deficiency triggers increased expression of neuroinflammatory markers 
in the brain, further supporting a role for immune activation in driving pathogenesis in 
leukodystrophies (Haud et al., 2010). However, as for most rare monogenic leukodystrophies, 
there is no treatment and the exact contribution of the immune system to the pathology is still 
obscure. 
 
We therefore hypothesised that the early onset of RNAseT2-deficient leukoencephalopathy is 
caused by abnormal immune activity during brain development. In this current study, we utilise 
the ex utero development of zebrafish larvae and its optical transparency to study the role of 
RNAseT2 during early brain development. Using a combination of transgenic zebrafish and 
CRISPR/Cas9, we identified dysfunctional microglia in brains of rnaset2-deficient larvae 
displaying profound morphology defects and failing to clear apoptotic cells in the developing 
brain. This reduction in brain integrity was accompanied by locomotor defects at larval stages, 
and further validated in adults using behavioural tests. Furthermore, tissue-specific expression 
of rnaset2 rescued microglial defects in rnaset2 zebrafish mutants.  
Our findings identify dysfunctional microglia as early markers of the pathology, highlighting 
a critical role for the immune system in disease development from its early stages. We propose 
a new mechanism by which failure of microglia to clear apoptotic neurons during development 
triggers irreversible neuroinflammation in the early brain, with negative impact on brain 
integrity. Our results identify the microglia as a new cellular target for therapies, opening the 
possibility of gene therapy and bone marrow transplant to treat this rare leukodystrophy.  
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Results 
 
Transcriptome microarray profiling in rnaset2AO127 mutant reveals increased immune 
responses in the brain. 
To investigate a role for the immune activation in rnaset2-deficient zebrafish, we adopted a 
unbiased approach to study differential gene expression in rnaset2AO127 mutant. Microarray 
analysis was performed on whole rnaset2AO12 and WT siblings during early development at 28 
hours post fertilisation (hpf) and 3days post fertilisation (dpf), and on brain samples of 1-year-
old adult zebrafish (Figure 1A). Biological pathway analysis identified 12 pathways 
differentially regulated in adult brain, with 7 involving the immune system (Figure 1B). The 
genes from Ôimmune systemÕ, Ôdefence responseÕ and Ôinnate immune responseÕ pathways were 
mostly upregulated in mutant samples (Figure 1B). 35% of the innate immune response genes 
are upregulated in mutant samples (Figure 1C), suggesting a strong immune response in the 
brain of mutants. Similar analysis did not reveal any significant pathway change in 28hpf 
samples, and only identified variations in cell cycle pathways at 3dpf (Sup. Figure 1). 
Additionally, our primary analysis showed that biological repeats from each time point 
clustered together, with the adult brain samples showing a clear separation from the embryonic 
time points (Sup. Figure 2). This suggests that the major dysregulations in gene expression 
happen in adulthood, with few differences being detectable in early embryonic timepoints 
looking at the whole animal level.  
Interestingly, most genes in the GO Ôresponse to virusÕ pathway were up-regulated in brains of 
adult rnaset2 deficient zebrafish (Sup. Figure 3), providing supporting evidence that 
RNASET2-deficient leukodystrophy resembles a cytomegalovirus brain infection (Henneke et 
al., 2009), and further demonstrating that our rnaset2 mutants recapitulate the human disease.  
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Figure 1: Immune system activity is upregulated in brains of rnaset2  mutants. 
A. Venn diagram of differentially expressed genes across the three timepoints of rnaset2AO127 mutant 
and WT samples used for microarray experiment. 
B. Differential expression (DE) graph showing the enriched pathways identified by clusterProfiler in 
adult brain. The proportion of individual genes belonging to each pathway is displayed in dark blue for 
up-regulated and light blue for down-regulated expression. The p-value for the enrichment of each 
pathway is stated below the pathway name.  
C. Heatmap of genes belonging to innate immune response GO pathway showing normalised 
expression values and all replicates of the adult time point. Genes are ordered according to the 
magnitude of difference between rnaset2AO127 mutant and WT samples (with red indicating higher 
expression in mutant). Each row is annotated with the gene name and colour-coded bars at the top to 
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indicate whether the gene is up-(dark blue) or down-(light blue) regulated, or not significant at the 
adjusted p-value threshold of 0.05. The -10log of the adjusted p-value is also shown.  
D. qPCR analysis of rnaset2 and immune response genes: mxa, il1beta, isg15, ifnF1 cellular and ifnF1 
secreted from dissected brain from 3-month-old WT siblings and rnaset2sh532. Expression relative to 
two reference genes combined rpl13 and ef1a. n=8 from 2 independent experiments, two-tailed Mann-
Whitney U test, p value shown on individual graphs. 
 
 
A CRISPR/Cas9 rnaset2sh532 mutant recapitulates previous rnaset2AO127 mutant.  
To further characterise the immune response triggered with the loss of rnaset2, we generated a 
second mutant allele by CRISPR/Cas9 in the rnaset2 gene by targeting the same exon as our 
previous rnaset2AO127 mutant, as our previous mutant was lost. This new rnaset2sh532 mutant 
allele possesses an 8bp deletion in exon 5 (Sup. Figure 4A) which creates a STOP codon before 
the second catalytic domain resulting in a truncated rnaset2 protein (Sup. Figure 4B), similar 
to our previous mutant (Haud et al., 2010). Homozygous and wild type (WT) sibling pairs were 
raised from a heterozygous in-cross and genotyped by high resolution melt curve analysis 
and/or restriction digest (Sup. Figure 4C, D). These fish were used to generate F2 homozygous 
(rnaset2 sh532) and WT siblings which were viable and fertile, as observed with our previous 
mutant. The previous rnaset2AO127 mutant had a characteristic high uptake of acridine orange, 
a dye accumulating in lysosomes highlighting the lysosomal storage defects (Haud et al., 
2010), a phenotype which is recapitulated by our rnaset2sh532 mutant (Sup. Figure 5).  
To determine whether immune response genes were also upregulated in the CRISPR mutant, 
we performed qPCR analysis on brains from 3-month-old rnaset2sh532 mutant and WT siblings 
using upregulated genes identified in the microarray profiling of rnaset2AO127. rnaset2 
expression was decreased 3-fold compared to WT siblings (Figure 1D) suggesting nonsense-
mediated RNA decay. Expression analysis of immune response genes confirmed upregulation 
of IL-1b (il1beta), interferon phi 1 genes (ifnϕ1 cellular and ifnϕ1 secreted) and antiviral genes 
(mxa and isg15) (Figure 1D). These results demonstrate that our new CRISPR/Cas9 
rnaset2sh532 mutant faithfully recapitulates the previous ENU-generated mutant. 
 
rnaset2sh532 mutants exhibit abnormal behaviour in adult and larval stages.  
As the first generation of homozygous and WT siblings generated from genotyped F2 reached 
adulthood, we noticed a clear tilted swimming phenotype in 8-month-old rnaset2sh532 mutants 
(Sup. Movie 1). Animals with tilted swimming behaviour were separated from the rest of the 
group for further analysis, after which this mild swimming phenotype developed into abnormal 
spiralling. They were therefore culled humanely before they deteriorated further. To perform 
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an unbiased swimming behaviour analysis on the rest of the clutch, we used the ViewPoint 
system and recorded normal swimming behaviour for 10 minutes. WT adults exhibited 
exploratory behaviours, demonstrated by visiting all 4 quadrants of the tank equally (Figure 
2A). Swimming and exploratory behaviours were significantly altered in rnaset2sh532 adults, 
who swam in repetitive stereotyped patterns restricted to a single quadrant in which they spent 
the majority of their time (Figure 2B-C). Interestingly swimming speed and distance travelled 
was not different (Sup. Figure 6).  
 
RNAseT2-deficient patients present with severe locomotor disabilities, including spasticity 
and dystonia, which arise in the first year of the patient life (Henneke et al., 2009). To assess 
locomotion in early life, we performed locomotion tests at 5dpf using the Zebrabox ViewPoint 
system. We measured the swimming activity of 5dpf rnaset2sh532 mutants relative to age-
matched WT siblings over 20 minutes, alternating light and dark phases (Pant et al., 2019). We 
found that rnaset2sh532 larvae were hypoactive compared to WT siblings (Figure 2D-G). Total 
swimming distance over a period of twenty minutes of alternating light and dark was decreased 
in mutants compared to wild types, with hypoactivity accentuated in dark phases (Figure 2D, 
E p=0.0223, p=0.0482). These early onset of locomotor disabilities in the rnaset2sh532 larvae 
suggest that the brain integrity is compromised during early stages of development.  
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Figure 2: Locomotion tests reveals that rnaset2sh532 mutant have abnormal behaviour in adult and 
larval stages.  
A,B. Representative traces of movement from 8-month-old adults WT siblings (A) and rnaset2sh532 (B) 
in all four quadrants with quadrant number 1 representing the quadrant most visited and quadrant 4 the 
least visited.  
C. Quantification of quadrant analysis in adult. n=4 using a contingency table and a Chi-square analysis 
p<0.0001. 
D,E. Swimming activity of 5dpf embryos as measured by distance travelled across a twenty minute 
period of alternating light and dark (D) and in dark phases only (E). n=56-67 larvae from 3 independent 
experiments, two-tailed Mann-Whitney U test p=0.0223 (D) and p=0.0482 (E).  
F,G. Examples of movement from 5dpf WT siblings (F) and rnaset2sh532 larvae during 1 minute(G). 
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Increased numbers of apoptotic cells in 5dpf rnaset2sh532 mutants are due to functionally 
impaired microglia. 
To characterise the early neuropathology and assess brain integrity in rnaset2sh532 mutants, we 
analysed the level of neuronal apoptosis in the brain using the TUNEL ApopTag kit. A wave 
of neuronal apoptosis occurs in the developing zebrafish brain at 2dpf and is accompanied by 
an influx of embryonic macrophages to the brain (Herbomel et al., 2001). These macrophages 
differentiate into microglia and begin to phagocyte apoptotic cells- a clearance that is 
completed by 5dpf  (Casano et al., 2016; Xu et al., 2016). Quantification of apoptotic cell 
number in mutants identified a more than 2-fold increased at 5dpf (Figure 3A,C). Interestingly, 
we found no difference at the earlier timepoint of 3dpf (Sup. Figure 7). This shows that the 
initial number of dying neurons is unchanged in mutants and suggest a potential defect in 
apoptotic cell clearing by microglia.  
 
To confirm that this increased in number of apoptotic cells in mutants are due to microglial 
dysfunction and not to increased dying neurons, we depleted macrophages and microglia by 
targeting irf8 using the CRISPR/Cas9 system. Using the CRISPR/Cas9 approach resulted in a 
more robust depletion of microglia at 5dpf compared to the irf8 antisense morpholino (Figure 
3 A-C), an approach commonly used to deplete macrophages and microglia at earlier stages 
(Li et al., 2011; Shiau et al., 2015). As expected and previously shown (Villani et al., 2019), 
depletion of microglia in WT resulted in a 3-fold increase numbers of apoptotic cells compared 
to control injected larvae at 5dpf (Figure 3D,E,G). Depletion of microglia in rnaset2sh532 
mutants resulted in the same number of apoptotic cells than in depleted WT (Figure 3D,F,G). 
We therefore concluded that the rate of neuronal apoptosis is normal in mutants and that the 
increased number of apoptotic cells in mutant is due to a defect in clearing of dead cells by 
microglia.  
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Figure 3: The increased number of apoptotic cells in 5dpf rnaset2sh532 mutant is due to 
dysfunctional microglia. 
A-C. Injection of irf8 crRNA is the optimal method for microglia depletion at 5dpf. A. 
Representative images of fish with normal microglia number, less than 15 and no microglia. Scale bar 
50µm B,C. Quantification of microglia depletion after irf8 morpholino (MO) injection at 500µM and 
irf8 crRNA at 50µM. 3 biological replicates, n=120. 
D. Diagram of experimental flow. Injection of irf8 crRNA or Control Tracr+Cas9 was performed into 
1-cell stage embryos, which were raised until 5dpf and microglia-depleted larvae were selected in irf8 
crRNA injected animals. Control and depleted larvae were fixed and stained for apoptotic cells using 
TUNEL assay. 
E,F. Representative images of apoptotic cells (as visualised by TUNEL staining) in brains of 5dpf 
rnaset2sh532 mutants and WT siblings in Cas9+TracrRNA injected control (E) and following injection 
of irf8 crRNA (F).  
G. Quantification of apoptotic cells in the optic tectum (OT). n=125-131 from 3 independent 
experiments, using multiple two-tailed U-test with BonferroniÕs multiple comparisons test (***: 
p<0.001, ****: p<0.0001).  
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Microglia display impaired morphology and increased number in rnaset2sh532 mutants. 
To further characterise microglial defects in rnaset2sh532 mutants, we analysed microglial 
number and morphology using the fluorescent reporter line Tg(mpeg1:mCherryCAAX)sh378 
labelling the membrane of macrophages and microglia. Confocal images of the optic tectum at 
5dpf revealed that microglia were more numerous in mutant brains at 5dpf (Figure 4A-C, p= 
0.0077). Subsequent morphology analysis identified that microglia in mutant brains were more 
circular with a higher circularity index (Figure 4A,D,E, p<0.0001) and contained a high 
number of vacuoles labelled using the  membrane transgenic line 
Tg(mpeg1:mCherryCAAX)sh378 (Sup. Figure 8). This circular and engorged phenotype was 
reduced in homozygous mutants generated from a heterozygous in-cross, suggesting that 
maternal contribution of rnaset2 in early development is critical for maintaining a normal 
microglia morphology (Sup. Figure 9). To determine if loss of rnaset2 affects all macrophages, 
we assessed macrophage innate immune function by studying responses to tissue damage 
induced by caudal tail fin transection (Morales and Allende, 2019). No difference was 
identified in macrophage recruitment to the wound site at 24hpi (Figure 4A,F,G), suggesting 
that loss of rnaset2 disrupts microglial function in the CNS without affecting the innate 
immune responses in the periphery.  
 
Tissue-specific rescue of rnaset2 restores microglial morphology in rnaset2sh532 mutant 
To further investigate the microglial phenotype identified in rnaset2sh532 mutants, we rescued 
rnaset2 expression by re-expressing WT rnaset2 in the rnaset2sh532 mutant. Rescue plasmids 
were built using gateway cloning to rescue expression in whole larvae (using the ubiquitous 
ubi promoter), specifically in macrophages/microglia (using the mpeg1 promoter), or 
specifically in neurons (using the huc promoter). All constructs contained a WT rnaset2 middle 
entry vector, and a blue eye marker to allow screening of positive larvae. Ubiquitous expression 
of rnaset2 fully rescued the brain phenotype observed in the rnaset2sh532 mutants, such that 
there was no difference in microglia circularity index compared to WT microglia (Figure 
5A,B,D,E, p<0.0001). Re-expression of rnaset2 specifically in macrophages and microglia 
using the mpeg:rnaset2 construct also rescued the circularity index, but to a lesser degree than 
in WT (Figure 5A,B,D, p<0.001, Sup. Figure 10A). Interestingly, rescue of rnaset2 specifically 
in neurons using the huc:rnaset2 construct achieved complete rescue of the microglia circular 
phenotype as seen when using the ubiquitous rescue (Figure 5A,B,E, p<0.0001, Sup. Figure 
10B). These results demonstrate that rescuing rnaset2 specifically in microglia or in neurons 
can alleviate developmental microglial defects. This highlights cell-specific strategies for 
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targeted therapy, representing exciting therapeutic avenues for treatment of rnaset2sh532 
deficient leukoencephalopathy.  
 
 
Figure 4: Microglia display impaired morphology and increased number in rnaset2sh532 mutant. 
A. Diagram of a dorsal view of 5dpf zebrafish larvae with red boxes highlighting the brain and tail fin 
regions imaged in the next panels. 
B,C. Microglia count in the optic tectum of 5dpf WT siblings and rnaset2sh532 larvae. B. Representative 
images of the whole head of 5dpf larvae with optic tectum outlined (dotted white line). Scale bar 70µm. 
C. Quantification of microglia number in the optic tectum. n=154-173 larvae from 3 independent 
experiments, two-tailed Mann-Whitney U test p<0.0001.    
D,E. Analysis of microglia circularity in the optic tectum in 5dpf WT siblings and rnaset2sh532 larvae. 
D. Representative images of microglia morphology using the 40x objective. Scale bar 21µm E. 
Quantification of microglia circularity using the circularity index analysis from Fiji. n=48-50 larvae 
from 3 independent experiments, two-tailed Mann-Whitney U test p=0.6944.    
F,G. Analysis of macrophage numbers at tissue damage site in 3dpf WT siblings and rnaset2sh532 larvae. 
F. Side view of tail fin injury representative images of macrophages at wound site at 24 hours post 
injury. Scale bar 50µm G. Quantification of macrophage numbers at the wound site 24 hours post injury. 
n=48-50 larvae from 3 independent experiments, two-tailed Mann-Whitney U test p=0.6944.  
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Figure 5: Tissue-specific rescue of rnaset2 restores microglial morphology in rnaset2sh532 mutant 
A. Diagram of a dorsal view of a 5dpf zebrafish head with red box highlighting the region imaged in 
the next panels. 
B. Representative images of microglia morphology in 5dpf WT siblings and rnaset2sh532 larvae using 
the 40x objective. Scale bar 100µm 
C. Representative images of microglia morphology using the 40x objective in 5dpf rnaset2sh532 larvae 
injected at one-cell stage to rescue expression of the rnaset2 gene either ubiquitously, or in macrophages 
and microglia, or in neurons. Scale bar 100µm. 
D,E. Quantification of microglia circularity after rescue of rnaset2 expression ubiquitously and in 
macrophages/microglia (D) and after rescue of rnaset2 expression ubiquitously and in neurons (E) 
using the circularity index analysis from Fiji. n=64-132 larvae from 3 independent experiments, 
Kruskal-Wallis test with DunnÕs multiple comparisons p<0.0001.    
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Discussion 
 
We have identified dysfunctional microglia as a new early marker of the pathology in 
RNAseT2-deficient leukoencephalopathy. Our results also demonstrate that microglia-specific 
interventions can alleviate microglial defects in rnaset2-deficient zebrafish, therefore 
highlighting a cell specific therapeutic approach to be investigated in patients.  
 
RNAseT2-deficient leukoencephalopathy was already proposed to be classified as a lysosomal 
storage disorder (LSD) from our previous study, showing accumulation of ribosomal RNA 
(rRNA) in neurons (Haud et al., 2010). The specific rounded and engorged microglial 
phenotype in rnaset2sh532 mutants is indeed reminiscent of an LSD and reinforces our initial 
proposal. Although these microglial defects have not yet been described in RNAseT2-deficient 
leukoencephalopathy patients, they still represent an early marker of the pathology and a 
potential therapeutic target for RNASET2-deficient leukoencephalopathy. 
 
In our model, we showed increased number of apoptotic bodies in brain tissue caused by failure 
of microglia to clear dying cells. Defects in the clearance of apoptotic neurons by microglia 
can promote additional neuronal death (Peri and Nsslein-Volhard, 2008; Casano et al., 2016; 
Villani et al., 2019) and have been associated with WMLs in neurodegenerative conditions and 
ageing (Raj et al., 2017; Rissanen et al., 2018). Additionally, increased apoptosis in the brain 
acts as a signal for brain entry of macrophages (Casano et al., 2016; Xu et al., 2016), which 
can explain the increased number of microglia observed in mutant brains. Cumulative arrival 
of microglia in the brain could eventually clear up the brain from apoptotic bodies, but at the 
expense of accumulating engorged microglia which could potentially secrete stress factor and 
become neurotoxic. This could trigger a ÔsnowballÕ effect, by which rnaset2-deficient 
microglia phagocytose a fixed number of dying neurons before reaching saturation- resulting 
in more microglia entering the brain to create a constant neuroinflammatory state. Future 
microglia-specific transcriptomic studies will be informative to elucidate their inflammatory 
profile. 
 
Tissue-specific rescue of rnaset2 expression using a neuronal promoter fully restored microglia 
morphology compared to a partial rescue with a microglia promoter. This could be due to the 
sheer number of neurons expressing rnaset2 in the case of the neuronal rescue, as opposed to 
a few microglia only in the case of the use of the microglia promoter.  Deficient microglia 
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could inherit the corrected version of the protein by engulfing rescued neuron. Cross-
correction, the phenomenon at the origin of enzyme replacement therapy,  can also be a 
mechanism as neurons could be secreting extracellularly the rnaset2 protein which could then 
be taken up by surrounding microglia (Fratantoni et al., 1968).  
 
Most importantly, to our knowledge, our zebrafish model is the first man-made animal model 
of a leukodystrophy that fully recapitulate the patient brain phenotype throughout development 
and upon adulthood. Murine models of leukodystrophies have failed to reproduce all aspect of 
the human disease with a recent RNASET2-deficient rat model showed deficiency in object 
recognition memory but showed no locomotor or spatial memory defects (Sinkevicius et al., 
2018). The rnaset2 zebrafish mutants shows hypoactivity in larval stages and tilted swimming 
in adulthood with an impaired exploratory phenotype. The adult tilted swimming phenotype 
can be caused by defects in the vestibular righting reflex or motor deficit (Kalueff et al., 2013).  
Vestibular defects a due to impaired ear development or impairment of sensory neurons within 
the inner ear (Whitfield, 2002) and recapitulates the sensorineural hearing loss diagnosed in 
patients (Henneke et al., 2009). Therefore, our study places the rnaset2sh532 zebrafish mutant at 
the forefront of leukodystrophy pre-clinical animal models and will be used to develop 
therapies targeting the microglial population. 
 
Our study identifies an important role for the ribonuclease T2 protein in early brain 
development and reveals that deficient microglia could underpin the pathology of RNAseT2-
deficient leukoencephalopathy. Here we report multiple features of neuroinflammation 
including apoptosis, increased immune response, white matter pathology and neuromotor 
deficits in the form of impaired locomotion in larval and adult rnaset2-deficient zebrafish 
mutants. We provide evidence to focus on therapies that can target the microglial population, 
such as gene therapy and haematopoietic stem cell transplantation. These therapies are already 
being used in clinical trials for LSDs and other types of leukodystrophies (Penati et al., 2017; 
Ohashi, 2019; Schiller et al., 2019) and could therefore be adapted to treat children suffering 
from RNAseT2-deficient leukoencephalopathy. 
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Materials and Methods 
 
Zebrafish husbandry and ethics 
All zebrafish were raised in the Bateson Centre at the University of Sheffield in UK Home 
Office approved aquaria and maintained following standard protocols (Nsslein-Volhard and 
Dham, 2002). Tanks were maintained at 28¡C with a continuous re-circulating water supply 
and a daily light/dark cycle of 14/10 hours. All procedures were performed on embryos less 
than 5.2 dpf which were therefore outside of the Animals (Scientific Procedures) Act, to 
standards set by the UK Home Office. We used the Tg(mpeg1:mCherryCAAX)sh378 labelling 
the membrane of macrophages and microglia (Bojarczuk et al., 2016), the previously ENU-
generated rnaset2AO127 mutant and nacre wild type (WT) to generate the new CRISPR/Cas9 
rnaset2sh532 mutant. 
 
Microarray experiment and analysis 
RNA was isolated from pooled dechorionated embryos at 28 hour post fertilisation (hpf), 3 day 
post fertilisation (hpf) and dissected whole adult brains using TRIzol (Invitrogen), following 
the manufacturerÕs protocol. The integrity of the RNA was confirmed using the Agilent 2100 
BioAnalyzer, using only samples with an RNA integrity number of at least 8. 
Genome-wide expression profiling was performed using the Zebrafish (v3) Gene Expression 
4x44K Microarray (Agilent G2519F) containing 43803 probes according to the manufacturerÕs 
instructions. The probe sequences for this array platform were re-annotated using the 
ReAnnotator pipeline (Arloth et al., 2015) against reference genome danRer11 in order to 
obtain updated gene symbols. 
Scanned raw data were normalised using quantile normalisation, and then filtered using the 
ReAnnotator results so that only probes matching the exons of their target gene were retained. 
In the case of genes with more than 1 probe, the probe with the highest inter-quartile range was 
chosen as the representative probe for the gene. 
Differential expression analysis was conducted using a linear model framework and empirical 
BayesÕ shrinkage implemented in the limma Bioconductor package (Ritchie et al., 2015). 
Genes with an adjusted p-value <0.05 were taken forward to enrichment analysis with the 
clusterProfiler Bioconductor package (Yu et al., 2012). 
 
 
 
 17 
CRISPR/Cas9 design and injection 
Synthetic SygRNA¨ consisting of gene specific CRISPR RNAs (crRNA) (Sigma) and 
transactivating RNAs (tracrRNA) (Merck) in combination with cas9 nuclease protein (Merck) 
was used for gene editing. TracrRNA and crRNA were resuspended to a concentration of 50µM 
in nuclease free water containing 10mM Tris-HCl ph8. SygRNA¨ complexes were assembled 
on ice immediately before injection using a 1:1:1 ratio of crRNA:tracrRNA:Cas9 protein. We 
used the following crRNA sequences, where the PAM site is indicated in brackets:  rnaset2 
(CCG)AGATCTGCTAGAACCATCTT, irf8 GCGGTCGCAGACTGAAACAG(TGG). A 2nl 
drop of SygRNA¨:Cas9 protein complex was injected into one-cell stage embryos.  
rnaset2 crispants were raised and screened (see below) to select a suitable mutation for a stable 
line.  
Successful irf8 crispant were phenotypically identified by injecting the SygRNA¨:Cas9 
complex into the Tg(mpeg1:mCherryCAAX)sh378 and selecting embryos with no microglia at 
5dpf. Control injection contained TracrRNA and Cas9 nuclease only.  
 
Generation of rnasetsh532 mutant 
To determine the efficiency of CRISPR/Cas9 to induce site-specific mutations in injected 
larvae, we used high-resolution melt curve (HMRC) analysis or PCR followed by Mwo1 
restriction digest (Sup. figure 4C,D). Genomic DNA (gDNA) was extracted from individual 
larvae at 2dpf. Larvae were placed individually in 90µl 50mM NaOH and boiled at 95¡ for 20 
minutes. 10µl Tris-HCL ph8 was added to adjust the pH and mixed thoroughly. Gene specific 
primers were designed using the Primer 3 web tool (http://primer3.ut.ee/) and primers with the 
following sequences were used to amplify a 142bp region: HRMCrnaset2_fw 
ACATACTACCAGAAATGGAG, HMRCrnaset2_rev GTAGTGCCTAAATGCATTTG. 
HMRC analysis was run using the CFX96 Bio-rad qPCR machine with the Bio-Rad Precision 
Melt Analysis software using the following reaction:  gDNA 1µl, 5ul DyNAmo Flash SYBR 
Green (Thermofisher), 0.5µl of each primers 10µM and 4µl of water. The program used was: 
Step 1: 95¡C for 2min, Step 2: 95¡C for 10sec, Step 3: 60¡C for 30sec, Step 4: 72¡C for 30sec, 
Step 5: 95¡C for 30sec, Step 6: 60¡C for 10min, Step 7: 95¡C for 20sec with Step 2 to 4 repeated 
44 times and increment of 0.2¡C  every 10sec between Step 6 and Step 7. 
Potential founders were outcrossed and gDNA was extracted from 8 embryos from each 
progeny. HMRC was used to identify INDELS in progenies from founder 2 and 5, which were 
subsequently raised. Individual F1 adults were fin clipped and DNA of individuals with 
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INDELS was sequenced using same genotyping primers as above. An 8 base pair deletion 
causing a frame shift and an early stop codon in a similar region as our previous rnaset2 mutant 
was kept, given the Ôsh532Õ code and outcrossed to the Tg(mpeg1:mCherryCAAX)sh378 line. 
Heterozygous animals were in-crossed and genotyped. Homozygous (rnaset2sh532) and WT 
siblings (WT) were selected, separated and raised to adulthood. All experiments were done on 
in-crosses from each tank, except when stated otherwise in Sup. Figure 9.   
 
Adult behaviour tests 
As above, behavioural analysis was performed using the Zebrabox tracking system and 
Zebralab software (ViewPoint Life Science, France). 8- and 3-month-old wild type and mutant 
fish were matched for sex and size, before being placed individually into open field tanks and 
allowed to habituate for 30 minutes before recording. The walls of each tank were covered with 
white paper to ensure the animals were unable to interact or be distracted by their surroundings. 
Movement was tracked over a period of 10 minutes under constant light conditions. For 
quadrant analysis, the Zebrabox software was programmed such that the open field tank was 
divided into four equal quadrants, where quadrant 1 was the most active quadrant while 
quadrant 4 was the least. Distance travelled by each fish was pooled and averagedÑboth in 
total, and within each quadrantÑin Microsoft Excel, with the resulting data analysed in 
GraphPad Prism. 
 
Larval behaviour light/dark behaviour test 
Behavioural analysis was performed using the Zebrabox tracking system and Zebralab 
software (ViewPoint Life Science, France). 
To assess swimming behaviour in response to light, 5dpf embryos were transferred into 48-
well plates (one embryo per well) and allowed to habituate overnight. Swimming distance 
during a one-minute interval was recorded for twenty minutes during an alternating dark-light 
protocol (five minutes dark, followed by five minutes light). Total distance was calculated as 
the sum of the distance swam across all twenty intervals for a single fish. Response to changes 
in light intensity was defined as the distance swam in the minute after each light-to-dark or 
dark-to-light transition. Distance travelled by each fish was pooled and averaged and the 
resulting data was analysed using GraphPad Prism. Outliers that had not been tracked 
accurately over the recording period were manually excluded based on abnormal angles and 
straight lines generated by the Zebralab software. 
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irf8 Morpholino knockdown 
The irf8 modified antisense oligonucleotide-morpholino (Gene Tools) was used as previously 
reported by injecting 1nl of 0.5mM irf8 morpholino in the yolk of 1-cell stage embryos (Li et 
al., 2011). 
 
Acridine Orange assay 
A pool of twenty 5dpf WT and rnaset2sh532 mutant zebrafish larvae were incubated at 27¡C for 
20 minutes in 5µg/ml of Acridine Orange (Life Technologies) diluted in zebrafish E3 medium. 
The larvae were rinsed three times for 10 minutes in clean E3. Larvae were then sedated and 
chopped finely with a scalpel then transferred to a tube containing PBS with Liberase (Roche, 
reference 05401020001) at 40µg/ml. Samples were incubated at 37¡C for 30 minutes, with 
triturating of the mixture every 10 minutes to dissociate into a single cell suspension. Samples 
were centrifuged at 1000g for 6 minutes and resuspended in Leibovitz 15 media containing 
20% FBS and 5mM EDTA. After filtration to remove clumps of cells, samples were analysed 
using an ATTUNE Flow cytometry machine using the blue laser. 
 
Quantitative PCR 
RNA from brains of 3-month-old zebrafish was extracted in 500µl of Trizol (Invitrogen) and 
purified by adding 100µl of chloroform. After vigorous shaking, samples were spun down at 
4¡C for 20 minutes and the top phase was transferred to a new tube containing 300µl of 
isopropanol to precipitate the RNA overnight at -20¡C. RNA was washed in 70% ethanol and 
dried before being resuspended in RNAse-free water. cDNA synthesis was performed using 
2µg of RNA and the SuperScript II kit (Invitrogen) following manufacturer instructions. cDNA 
was diluted in 1:20 for qPCR. qPCR primers (Supplementary Table 1) were tested for 
efficiency (85%-105%) using a cDNA serial dilution. The qPCR reaction was run in a CFX96 
Bio-Rad machine as follow: 2µl of cDNA, 5ul DyNAmo Flash SYBR Green (Thermofisher), 
0.5µl of each primers 10µM and 3µl of water. The program used was: Step 1: 95¡C for 2min, 
Step 2: 95¡C for 10sec, Step 3: 60¡C for 30sec, Step 4: 72¡C for 25sec, Step 5: 95¡C for 30sec, 
Step 6: 65¡C for 10sec, Step 7: 95¡C for 20sec with Step 2 to 4 repeated 39 times and increment 
of 0.2¡C  every 10sec between Step 6 and Step 7.  
DCT was calculated using combined rpl13 and ef1a as reference genes and expression relative 
to endogenous control was calculated using the 2^(-DCT). 
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Microglia morphology and count 
To assess microglia morphology, 5dpf WT and rnaset2sh532 mutant zebrafish larvae were 
anaesthetised and imbedded in low melting point agarose containing tricaine (0.168 mg/ml; 
Sigma-Aldrich) and imaged using a 40x objective on a UltraVIEW VoX spinning disk confocal 
microscope (PerkinElmer Life and Analytical Sciences) confocal spinning disk microscope. 
100micron stacks were acquired using 0.5µm slices. For image analysis, stacks of 50µm were 
used to create a maximum projection and contours of each microglia (avoiding pigment cells) 
were drawn using a pen tablet (Intuos from Wacom). Using Fiji, we measured the circularity 
index (0-1) of each microglia and used these values to assess the circularity of each cell with 
the value of 0 being not circular and 1 as being perfectly circular. 
The same images were used to quantify the number of vacuoles in each microglia. We used the 
labelled microglia membrane from Tg(mpeg1:mCherryCAAX)sh378 to manually count 
vacuoles. Number of vacuoles in microglia exceeding 20 were capped due to the difficulty to 
be accurate after this number.    
For microglia count, 5dpf larvae were imaged under the 10x objective of the spinning disk 
microscope. Stacks of 100µm were generated with 2µm thickness and microglia were counted 
in the optic tectum region of each larvae by drawing a region of interest around the optic tectum 
first using the reference brightfield image.  
 
Macrophage recruitment assays 
To induce an inflammatory response, 2dpf WT and rnaset2sh532 mutant zebrafish larvae in the 
Tg(mpeg:mCherryCAAX)sh378 background were dechorionated and anaesthetised using 
Tricaine. Tail-fins were transected consistently using a scalpel blade (5mm depth, WPI) by 
slicing immediately posterior to the circulatory loop, ensuring the circulatory loop remained 
intact as previously described. Larvae were left to recover in fresh E3 media at 28¡C. Larvae 
were mounted for imaging 24 hours post injury in a 1% low melting point agarose solution 
(Sigma-Aldrich) containing tricaine. Images were taken using an Andor Zyla 5 camera (Nikon) 
and an mCherry specific filter with excitation at 561nm. 10 z-planes were captured per larvae 
over a focal range of 100µm. Maximum intensity projections were generated by NIS elements 
(Nikon) to visualise all 10 z-planes. 
 
 
 
TUNEL assay 
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Fish larvae at 5dpf were fixed in 4% PFA and the TUNEL assay was performed according to 
standard protocol using ApopTag Kit (Millipore). Briefly, 5dpf larvae were incubated with 
proteinase K (20µg/ml) for 2 hours to permeabilise the tissue. Samples were fixed for 20 
minutes in PFA at room temperature before being placed at -20¡C in 1:2 acetone:ethanol for 7 
minutes. Following incubation at 37¡C with 50µl equilibration buffer for 1 hour, the reaction 
solution (16µl TdT enzyme and 30µl reaction buffer; Apoptag Kit) was added to the embryosÑ
again, incubating at 37¡C for 90 minutes. Embryos were then placed in 200µl stop buffer 
(Apoptag kit) for 2 hours at 37¡C, before placing in antibody and blocking solution (62µl anti-
Dig Fluorescein and 68µl blocking solution) overnight at 4¡C. The following morning, samples 
were thoroughly washed in PBST (PST + 0.1% Tween) and fixed in PFA for 30 minutes at 
room temperature. All liquid was removed and embryos thoroughly rinsed with PBST between 
each stage (5 minute washes at room temperature, repeated three to four times as needed). 
Following completion of TUNEL staining, samples were imaged on the inverted UltraVIEW 
VoX spinning disk confocal microscope (PerkinElmer Life and Analytical Sciences) using the 
brightfield and GFP channel by acquiring stacks of approximately 100µm with 2µm per slice. 
Using Fiji, the optic tectum region was outlined with the free hand drawing tool using the 
brightfield image and counting of number of apoptotic cells was performed using the automatic 
thresholding and particle count. Counting was performed for all samples from each experiment 
within the same day to minimise intra-observer variation.  
 
Statistical analysis 
All statistical analysis were performed in GraphPad Prism where data was entered using either 
a column (2 samples, 1 variable only) or a grouped table (more than 2 samples or 2 variables). 
Sample distribution was assessed using frequency of distribution analysis. Non-parametric 
tests were used for not normally distributed dataset with post-test (for multiple comparisons) 
described for each experiment. All experiments were repeated at least twice, with the number 
of biological replicates and n (experimental unit) number stated for each experiment in figure 
legends. Contingency tables were used for adult zebrafish behaviour analysis with FisherÕs 
exact-test.  
p values are indicated and a star system is used instead for graph with multiple comparisons: 
*=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001. Following the recommendation of the 
American Statistical Association we do not associate a specific p value with significance  
(Wasserstein et al., 2019). 
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Cloning of rescue constructs 
The rnaset2 cDNA was amplified from the PCGlobin vector previously used (Haud et al., 
2010) using the following Attb primers: rnaset2_AttB1fwd 
GGGGACAAGTTTGTACAAAAAAGCAGG-CTGGATGAGATTCATTGCATTTGCTG, 
rnaset2_AttB2rev GGGGACCACTTTGTACAAGAA-
AGCTGGGTGCTACGCTTGCACCGGTGGGTA. Using the BP reaction, the PCR product 
was cloned into the p221DONOR vector which was used for the following LR reactions. To 
create the positive control construct ubi:rnaset2:pA construct, we used the p5ÕE-ubi 
(Mosimann et al., 2011), pME-rnaset2, p3ÕE-polyA into the cryCFPpDest vector. To create 
the mpeg1:rnaset2:pA construct, we used the p5ÕE-mpeg1 (Ellett et al., 2011), pME-rnaset2, 
p3ÕE-polyA into the cryCFPpDest vector. To create the huc:rnaset2:pA construct, we used the 
p5ÕE-huc (cloned into p5ÕE using the following primers and restriction sites: Xhohuc_fwd 
CGACTGCTCGAGCTTCCGGCTCGTATGTTGTG and Bamhuc_rev 
GCAGGATCCGGTCCTTCGATTTGCAGGTC), pME-rnaset2, p3ÕE-polyA into the 
cryCFPpDest vector. Blue-eyed larvae were selected at 5dpf before imaging.  
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Supplementary files 
 
Supplementary Figure 1
Supplementary Figure 1: Differential expression (DE) graph showing the
enriched pathways identified by clusterProfiler in adult brain. The proportion
of individual genes belonging to each pathway is displayed in dark blue for up-
regulated and light blue for down-regulated expression. The p-value for the
enrichment of each pathway is stated below the pathway name.
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Supplementary Figure 2
Supplementary Figure 2: Cluster dendrogram of all timepoints used for
microarray analysis showing adult samples clustering separately from
embryonic timepoints. M=rnaset2ao127
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Supplementary Figure 3
WTrnaset2ao127
Adult brain
WTrnaset2ao127
3dpf
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28hpf
Supplementary Figure 3: Heatmap of the ‘Response to Virus’ pathway 
GO:0009615 in all time points
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Supplementary Figure 4: A. Diagram of the rnaset2 zebrafish gene with the
target gRNA on the WT strand and the selected 8bp deletion in exon 5 (E5) to
generate the new rnaset2sh532 allele.
B. Diagram of the WT rnaset2 protein and the resulting truncated protein in
the rnaset2sh532 mutant.
C. Traces of High Resolution Melt Curve of a WT, heterozygous (HET)
rnaset2sh532, and homozygous (HOM) rnaset2sh532mutant used for genotyping.
D. Agarose gel of genotyping of WT, HET and HOM using Mwo1 restriction
digest on PCR product flanking the Mwo1 site targeted by the rnaset2 crRNA
on exon 5 of the rnaset2 gene.
rnaset2sh532
GACATACTACCAGAAATGGAGAAATTCTGCCGAGATCTGCTAGAACCATCTTCCCCAAAATTTTG
E5
GACATACTACCAGAAATGGAGAAATTC               TCTGCTAGAACCATCTTCCCCAAAATTTTG********
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Supplementary figure 5: Acridine orange uptake is higher in 5dpf
rnaset2sh532mutant.
A. Flow cytometry Individual plot of WT and rnaset2sh532 unstained or
stained with acridine orange and analyse with gate used to measure acridine
orange signal using a GFP laser (BL1A).
B. Representative overlay of Acridine Orange uptake in 5dpf WT siblings (blue
line) and rnaset2sh532 (red line) larvae.
C. Quantification of acridine orange signal in WT and rnaset2sh532 . n=6 from 2
biological experiments, two-tailed Mann-Whitney U test p=0.0043.
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Supplementary Figure 6
Supplementary Figure 6: Movement
tracking of 8 month old adult fish
between WT and mutant for total
distance travelled across a 10 minute
interval. n=4, two-tailed Mann-Whitney
U test.
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Supplementary Figure 7
Supplementary Figure 7: A. Quantification of apoptotic cells in the optic
tectum (OT) between 3dpf WT siblings and rnaset2sh532 larvae. n=14-17 from
3 independent experiments, two-tailed Mann-Whitney U test. B.
Representative images from TUNEL positive cells labelled with Fluorescein
from 5dpf rnaset2sh532 larvae. Apoptotic cells are either located in the brain
tissue (white arrows) or located within microglia labelled in red by the
Tg(mpeg1:mCherryCAAX) line (white arrowheads).
p=0.99A
B
TUNEL mpeg1:mCherryCAAX merge
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Supplementary Figure 8
A
p<0.0001
Supplementary Figure 8:
Quantification of numbers of
vacuole in individual microglia.
Mutant counts were capped at 20
due to the lack of accuracy to
identify vacuole when there were
too many in each cell. n=80-104
larvae from 3 independent
experiments, two-tailed Mann-
Whitney U-test p<0.0001
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Supplementary Figure 9
Supplementary Figure 9: Maternal contribution alleviates defects in
microglia morphology. A. Representative images of microglia morphology
using the 40x objective in 5dpf rnaset2sh532 and WT siblings generated from
heterozygous incross. Scale bar 21 m
B. Quantification of microglia circularity n=173-181 larvae from 2
independent experiments, two-tailed Mann-Whitney U-test p<0.0001
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Dunn's multiple comparisons test Mean rank diff. Significant? Summary
WT vs. rnaset2sh532 -114.7 Yes ****
WT vs. rnaset2sh532 + ubi:rnaset2 -12.81 No ns
WT vs. rrnaset2sh532 + huc:rnaset2 -16.50 No ns
rnaset2sh532 vs. rnaset2sh532 + ubi:rnaset2 101.9 Yes ****
rnaset2sh532 vs. rrnaset2sh532 + huc:rnaset2 98.24 Yes ****
rnaset2sh532 + ubi:rnaset2 vs. rrnaset2sh532 + huc:rnaset2 -3.693 No ns
Dunn's multiple comparisons test Mean rank diff. Significant? Summary
WT vs. rnaset2sh532 -182.8 Yes ****
WT vs. rnaset2sh532 + ubi:rnaset2 -12.50 No ns
WT vs. rnaset2sh532 + mpeg:rnaset2 -116.1 Yes ****
rnaset2sh532 vs. rnaset2sh532 + ubi:rnaset2 170.3 Yes ****
rnaset2sh532 vs. rnaset2sh532 + mpeg:rnaset2 66.79 Yes ***
rnaset2sh532 + ubi:rnaset2 vs. rnaset2sh532 + mpeg:rnaset2 -103.5 Yes ****
Supplementary Figure 10
A
B
Supplementary Figure 10: Full results of statistical Krustkal-Wallis test with
Dunn’s multiple comparisons for rescue with mpeg:rnaset2 (A) and
huc:rnaset2 (B) from Figure 5.
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gene primer name sequence (5'-3')
ef1! ef1a_qPCR_fd CAGCTGATCGTTGGAGTCAA
ef1! ef1a_qPCR_rv TGTATGCGCTGACTTCCTTG
rpl13 rpl13_qPCR_fd TCTGGAGGACTGTAAGAGGTATGC
rpl13 rpl13_qPCR_fd AGACGCACAATCTTGAGAGCAG
rnaset2 Dre2_qPCR_F2 TTACTCGCTGGAGGATGTG
rnaset2 Dre2_qPCR_R2 GGTGTCTTCGCTGGACTTT
mxa mxa_qPCR_fwd GACCGTCTCTGATGTGGTTA
mxa mxa_qPCR_rev GCATGCTTTAGACTCTGGCT
isg15 isg15_qPCR_fwd AACTCGGTGACGATGCAGC
isg15 isg15_qPCR_rev TGGGCACGTTGAAGTACTGA
IFNϕ1 secreted IFNphi1sec_qPCR_fwd TGAGAACTCAAATGTGGACCT
IFNϕ1 secreted IFNphi1sec_qPCR_rev GTCCTCCACCTTTGACTTGT
IFNϕ1 cellular IFNphi1ic_qPCR_fwd ACGGCAGCCTGAAATACGTT
IFNϕ1 cellular IFNphi1ic_qPCR_rev GTCCTCCACCTTTGACTTGT
Supplementary Table 1
